| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1397146A2 Compositions and methods for inhibiting bone resorption |
| 03/17/2004 | EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1242406B1 Novel compounds |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP0971588B1 Novel cannabinoid receptor modulators |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | CN1483035A Sulfamidothienopyrimidines |
| 03/17/2004 | CN1483032A Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/17/2004 | CN1483026A Benzoylpyridazine |
| 03/17/2004 | CN1483024A Vla-4 inhibitors |
| 03/17/2004 | CN1483023A 3-arylindole derivatives and their use as cb2 receptor agonists |
| 03/17/2004 | CN1482135A Estrogen compound of bone tendency, preparing method and application thereof |
| 03/17/2004 | CN1482134A Estrogen compound of bone tendency, preparing method and application thereof |
| 03/17/2004 | CN1481881A Prepared Chinese traditional medicine for hyperplastic arthritis |
| 03/17/2004 | CN1481859A Capsule for regenerating bone |
| 03/17/2004 | CN1481853A Food-cure medicated wine which can cure bone arthralgia and preparation method |
| 03/17/2004 | CN1481850A Liquid for filth releasing and skin cleaning |
| 03/17/2004 | CN1481837A Preparation method and formula of moxibustion ramee strip with muskiness |
| 03/17/2004 | CN1481801A Tetracycline medication for prevention and cure of parkinsons and NO-related nerve retrogressive disease |
| 03/17/2004 | CN1142178C Novel peptides and remedy for bone diseases contg. same as active ingredient |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1142149C Novel pyridazine derivatives and drugs containing same as active ingredient |
| 03/17/2004 | CN1142148C Pyridazine derivatives and drugs containing the same as the active ingredient |
| 03/17/2004 | CN1141955C Rheumatism treating tincture of external use |
| 03/17/2004 | CN1141953C Traditional Chinese medicine capsule for osteomyelitis and process |
| 03/17/2004 | CN1141945C Traditional chinese medicine formulation treating rheumarthritis and its preparation method |
| 03/17/2004 | CN1141938C Usage of sodium threonic acid in preparing the medicine of prevention and curing osteoporosis |
| 03/17/2004 | CN1141918C Process for preparing recombined heterobone with strong anti-infection power |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706746 Thiadiazolidin-2,4-dione compound |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706709 Treating, for example, proliferative disorders including cancer |
| 03/16/2004 | US6706266 Oncostatin M antagonists |
| 03/11/2004 | WO2004020633A1 Human antihuman interleukin-6 antibody and fragment of the antibody |
| 03/11/2004 | WO2004020584A2 Antagonists of chemokine receptors |
| 03/11/2004 | WO2004020462A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | WO2004020440A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020434A1 Azaarene derivatives |
| 03/11/2004 | WO2004020433A1 Novel crystals |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004020427A1 The process for preparation of total coumarins from cortex fraxini and their use in medicine |
| 03/11/2004 | WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 03/11/2004 | WO2004020407A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 03/11/2004 | WO2004019958A1 Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| 03/11/2004 | WO2004019957A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004019936A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | WO2004019927A2 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation |
| 03/11/2004 | WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 03/11/2004 | WO2003099759A8 Preparation and application of transhintotalphenolic acid |
| 03/11/2004 | WO2003095607A3 Role of p62 in aging-related disease |
| 03/11/2004 | WO2003092599A3 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2003059323A3 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 03/11/2004 | WO2003057201A3 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 03/11/2004 | WO2003057133A3 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 03/11/2004 | WO2003053945A3 Urea derivatives and their use as vanilloid receptor antagonists |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003007873A3 Plasma protein matrices and methods for their preparation |
| 03/11/2004 | WO2003000695A8 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/11/2004 | WO2003000191A3 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048929 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048901 Increased water solubility and bioabsorption; treatment of CNS disorders such as depression and emesis |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048888 1,6-naphthyridineurea derivatives; treating excessive or undesirable angiogenesis and/or Tie2 receptor activity |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048881 Quinazoline derivatives with anti-tumour activity |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048865 Aliphatic amino group-substituted fused ring pyrimidines or pyridines such as 2,4 dichloro-pyrido-(2,3-d)- or -(3,2d)-pyrimidines, 5,7-dichloro-(1,6) napthyridines, or 2,4-dichloro-(1,8)napthyridines |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |